Oncternal Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Oncternal Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.68M, a 16.4% increase year-over-year.
  • Oncternal Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36M, a 18.3% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$41.7M, a 7.19% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$44.9M, a 43.3% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$31.4M, a 78.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$41.7M +$3.23M +7.19% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$44.9M -$13.6M -43.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$31.4M -$13.8M -78.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$17.5M +$15.6M +47% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$33.1M -$25.5M -336% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
2018 -$7.59M +$23.1M +75.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$30.7M -$4.72M -18.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$25.9M -$4.09M -18.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$21.8M +$8.51M +28% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$30.3M +$13.3M +30.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 -$43.6M +$6.13M +12.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$49.7M -$13.8M -38.5% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$35.9M -$51M -338% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $15.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.